Literature DB >> 32201080

Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection.

Junwen Luan1, Yue Lu2, Xiaolu Jin2, Leiliang Zhang3.   

Abstract

SARS-CoV-2 causes the recent global COVID-19 public health emergency. ACE2 is the receptor for both SARS-CoV-2 and SARS-CoV. To predict the potential host range of SARS-CoV-2, we analyzed the key residues of ACE2 for recognizing S protein. We found that most of the selected mammals including pets (dog and cat), pangolin and Circetidae mammals remained the most of key residues for association with S protein from SARS-CoV and SARS-CoV-2. The interaction interface between cat/dog/pangolin/Chinese hamster ACE2 and SARS-CoV/SARS-CoV-2 S protein was simulated through homology modeling. We identified that N82 in ACE2 showed a closer contact with SARS-CoV-2 S protein than M82 in human ACE2. Our finding will provide important insights into the host range of SARS-CoV-2 and a new strategy to design an optimized ACE2 for SARS-CoV-2 infection.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ACE2; Host range; SARS-CoV-2; Spike protein; Structure

Mesh:

Substances:

Year:  2020        PMID: 32201080      PMCID: PMC7102515          DOI: 10.1016/j.bbrc.2020.03.047

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


Introduction

Corona Virus Disease 2019 (COVID-19), which was reported from Wuhan city, Hubei province of China, has caused over 78,000 human infections and more than 2700 deaths (as of February 25, 2020) [1,2]. Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) was identified as the pathogen of COVID-19 [[1], [2], [3]]. After SARS-CoV and MERS-CoV, SARS-CoV-2 has become the third coronavirus that causes severe respiratory disease and human death [4,5]. Belonging to the subgenus sarbecvirus of Coronaviridae, both SARS-CoV-2 and SARS-CoV are human SARS-related coronavirus (SARSr-CoV). Its genome is a single-stranded RNA composed of about 30 kb nucleotides. SARS-CoV-2 encodes at least four major structural proteins, namely spike protein (S), membrane protein (M), envelope protein (E), and nucleocapsid protein (N) [6]. S protein, which is a type I glycoprotein, protrudes from the surface of the virus and can contact the host cell earlier. S protein has attracted great attention because of its function in receptor binding. Angiotensin-converting enzyme 2 (ACE2) binds to the receptor-binding motif (RBM) in the receptor-binding domain (RBD) of SARS-CoV and functions as a receptor for SARS-CoV [7,8]. ACE2 is widely distributed in heart, liver, testis, kidney, intestine and other tissues. It has the physiological functions of regulating heart and kidney function and controlling blood pressure [9]. Recently, it has been found that human ACE2 promoted the entry of SARS-CoV-2 into the cells [3,10]. RBD domain of SARS-CoV-2 interacts with human ACE2. Thus, ACE2 is defined as the receptor for SARS-CoV-2. The specificity of the interaction between virus and receptor determines the host tropism and host range. The origin of SARS-CoV-2 is presumed to be bat [3]. However, the intermediate host is not clear, and some studies suggest that pangolin is involved in the evolution of SARS-CoV-2 [11,12]. It is not clear which mammals are involved in the evolution of SARS-CoV-2 and which animals may be infected by SARS-CoV-2. By sequence alignment of key amino acids binding to RBD in ACE2, the interaction between RBD of SARS-CoV-2/SARS-CoV and mammalian ACE2 was predicted. Based on the potential interaction between S protein and mammalian ACE2, it was speculated that SARS-CoV-2/SARS-CoV preserved the ability to infect many mammals including cat, dog, pangolin and Chinese hamster. From the structure stimulation, we identified N82 in ACE2 show closer contact with F486 of SARS-CoV-2 S protein compared with M82 of ACE2.

Methods

Sequence analysis of RBM of S from SARS-CoV-2 and SARS-CoV

The S protein sequence of SARS-CoV-2 is YP_009724390.1, and the S protein sequence of SARS-CoV is NP_828851.1. RBM of SARS-CoV is from 424 to 494. RBM of SARS-CoV-2 is from 437 to 508.

Sequence analysis of mammal ACE2

A total of 42 mammalian ACE2 protein sequences were selected from the wild animal protection lists of Hubei Province and Jiangxi Province, primates, bats, dog, and cat. These sequences are as follows: hACE2: Homo sapiens (BAB40370.1), RhiACE2: Rhinopithecus roxellana (XP_010364367.2), MacmACE2: Macaca mulatta (NP_001129168.1), MuseACE2: Mustela erminea (XP_032187679.1), CamdACE2: Camelus dromedarius (XP_031301717.1), PlACE2: Procyon lotor (XP_031301717.1), PcACE2: Paguma larvata (AAX63775.1), RmACE2: Rhinolophus macrotis (ADN93471.1), RfACE2: Rhinolophus ferrumequinum (BAH02663.1), RsACE2: Rhinolophus sinicus (ADN93472.1), RlACE2: Rousettus leschenaultii (BAF50705.1), SsACE2: Sus scrofa (NP_001116542.1), MpfACE2: Mustela putorius furo (BAE53380.1), RatACE2: Rattus norvegicus (Q5EGZ1), MmACE2: Mus musculus (Q3URC9), ClfACE2: Canis lupus familiaris (J9P7Y2), FcACE2: Felis catus (A0A384DV19), MjACE2: Manis javanica (XP_017505752.1), RpACE2: Rhinolophus pearsonii (ABU54053.1), PvACE2: Pteropus vampyrus (XP_011361275.1), PoaACE2: Pongo abelii (NP_001124604.1), EcACE2: Equus caballus (F6V9L3), BtACE2: Bos taurus (Q58DD0), PtACE2: Pan troglodytes (A0A2J8KU96), OraACE2: Ornithorhynchus anatinus (F7FDA2), OvaACE2: Ovis aries (W5PSB6), PanACE2: Papio Anubis (A0A096N4X9), LaACE2: Loxodonta africana (G3T6Q2), SsdACE2: Sus scrofa domesticus (A0A220QT48), EeACE2: Erinaceus europaeus (A0A1S3APE5), OcACE2: Oryctolagus cuniculus (G1TEF4), NpACE2: Nyctereutes procyonoides (B4XEP4), VvACE2: Vulpes vulpes (A0A3Q7RAT9), PhcACE2: Phodopus campbelli (C7ECU7), MaACE2: Mesocricetus auratus (C7ECV1), CjACE2: Callithrix jacchus (F7CNJ6), SusACE2: Suricata suricatta (XP_029786256.1), HgACE2: Heterocephalus glaber (A0A0N8EUX7), DoACE2: Dipodomys ordii (A0A1S3GHT7), ItACE2: Ictidomys tridecemlineatus (XP_005316051.3), CpACE2: Cavia porcellus (XP_023417808.1), CgACE2: Cricetulus griseus (A0A061HZ66). Based on the known key sites in SARS-CoV S protein interacting with human ACE2, we analyzed whether these sites were conserved on ACE2 from wild mammals and domestic pets. Phylogenetic and molecular evolutionary analyses of ACE2 were conducted using MEGA version X [13]. Phylogenetic tree was generated with Jones-Taylor-Thornton (JTT) evolutionary model using Maximum Likelihood method.

Structure simulation of ACE2-RBD complex

The interaction interfaces of SARSr-CoV S and ACE2 from cat/dog/pangolin/Chinese hamster were simulated by Chimera software Ver 1.14 [14]. The simulation were based on the structures of hACE2 with SARS-CoV S RBD (PDB: 2AJF) [7] and hACE2 with SARS-CoV-2 S RBD (PDB: 6LZG).

Results

Sequence alignment of RBM from SARS-CoV-2 and SARS-CoV

Human ACE2 is the receptor for both SARS-CoV and SARS-CoV-2. According to the literature [15], the key amino acids (AAs) in the S protein of SARS-CoV interacting with human ACE2 are Y442, L472, N479, D480, T487, Y491 [7,15]. We compared the RBM in S protein of SARS-CoV-2 with that of SARS-CoV (Fig. 1 A). These amino acids corresponding to SARS-CoV-2 are L455, F486, Q493, S494, N501 and Y505 (Fig. 1A). Although five of six key AAs in SARS-CoV-2 are changed compared with SARS-CoV, the overall structure of interfaces of ACE2-RBM are similar (Fig. 1B).
Fig. 1

Alignment of RBM region of S proteins from SARS-CoV-2 and SARS-CoV. (A) Sequence alignment of RBM region of S protein from SARS-CoV-2 and SARS-CoV. ▲ represents the six key amino acids in the S protein interacting with human ACE2. For SARS-CoV, they are Y442, L472, N479, D480, T487 and Y491. The S protein sequence of SARS-CoV-2 comes from YP_009724390.1, and the S protein sequence of SARS-CoV comes from NP_828851.1. (B) Alignment of the structure of ACE2 recognition of RBD from SARS-CoV-2 and SARS-CoV. Human ACE2 (hACE2), SARS-CoV-2 RBD, and SARS-CoV RBD are in orange red, blue, and green, respectively. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

Alignment of RBM region of S proteins from SARS-CoV-2 and SARS-CoV. (A) Sequence alignment of RBM region of S protein from SARS-CoV-2 and SARS-CoV. ▲ represents the six key amino acids in the S protein interacting with human ACE2. For SARS-CoV, they are Y442, L472, N479, D480, T487 and Y491. The S protein sequence of SARS-CoV-2 comes from YP_009724390.1, and the S protein sequence of SARS-CoV comes from NP_828851.1. (B) Alignment of the structure of ACE2 recognition of RBD from SARS-CoV-2 and SARS-CoV. Human ACE2 (hACE2), SARS-CoV-2 RBD, and SARS-CoV RBD are in orange red, blue, and green, respectively. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

Sequence alignment of ACE2

The key AAs in hACE2 for interacting with RBM are K31, E35, D38, M82 and K353 [7,15]. Among them, K31 and K353 in hACE2 are most critical residues for RBM recognition. Because the overall structure of interfaces of ACE2-RBM in SARS-CoV-2 and SARS-CoV are similar, we analyzed the key RBD recognizing AAs of ACE2 protein from selected mammals, as shown in Table 1 . We predicted that the mammals whose ACE2 could bind to the S protein of SARS-CoV-2 and SARS-CoV were Homo sapiens, Rhinopithecus roxellana, Macaca mulatta, Mustela erminea, Paguma larvata, Rhinolophus macrotis, Rhinolophus sinicus, Rousettus leschenaultii, Sus scrofa, Mustela putorius furo, Canis lupus familiaris, Felis catus, Manis javanica (pangolin), Rhinolophus pearsonii, Pteropus vampyrus, Pongo abelii, Equus caballus, Bos taurus, Pan troglodytes, Ovis aries, Papio Anubis, Sus scrofa domesticus, Oryctolagus cuniculus, Vulpes vulpes, Phodopus campbelli, Mesocricetus auratus, Callithrix jacchus, Heterocephalus glaber, Ictidomys tridecemlineatus, and Cricetulus griseus (Chinese hamster). The mammals whose ACE2 could not bind to S protein of SARS-CoV-2 and SARS-CoV included Camelus dromedarius, Procyon lotor, Rhinolophus ferrumequinum, Rattus norvegicus, Mus musculus, Ornithorhynchus anatinus, Loxodonta africana, Erinaceus europaeus, Nyctereutes procyonoides, Suricata suricatta, Dipodomys ordii, and Cavia porcellus.
Table 1

Prediction of the RBD binding capacity of mammalian ACE2.

ACE2AA position
matched AAbinding capacity
31353882353
hACE2KEDMK5/5+
RhiACE2KEDMK5/5+
MacmACE2KEDMK5/5+
MuseACE2KEETK3/5+
CamdACE2EEDTK3/5
PlACE2NEETK2/5
PcACE2TEETK2/5+
RmACE2KKDNK3/5+
RfACE2DENNK2/5
RsACE2KKDNK3/5+
RlACE2KEDTK4/5+
SsACE2KEDTK4/5+
MpfACE2KEETK3/5+
RatACE2KEDNH3/5
MmACE2NEDSH2/5
ClfACE2KEETK3/5+
FcACE2KEETK3/5+
MjACE2KEENK3/5+
RpACE2KEDDK4/5+
PvACE2KEDAK4/5+
PoaACE2KEDMK5/5+
EcACE2KEETK3/5+
BtACE2KEDTK4/5+
PtACE2KEDMK5/5+
OraACE2QQDKK2/5
OvaACE2KEDTK4/5+
PanACE2KEDMK5/5+
LaACE2TEDDK3/5
SsdACE2KEDTK4/5+
EeACE2DQNNN0/5
OcACE2KEDTK4/5+
NpACE2KEETR2/5
VvACE2KEETK3/5+
PhcACE2KEDNK4/5+
MaACE2KEDNK4/5+
CjACE2KEDTK4/5+
SusACE2QEEAK2/5
HgACE2KEDAK4/5+
DoACE2NEDIK3/5
ItACE2KEDAK4/5+
CpACE2EKDAK2/5
CgACE2KEDNK4/5+
Prediction of the RBD binding capacity of mammalian ACE2. Next, we constructed a phylogenetic tree for mammalian ACE2 proteins. The ACE2 protein sequences of 42 mammalian animals were compared by ClustalW method of MEGA-X software. Then the JTT model of maximum likelihood method was used to construct ACE2 phylogenetic tree. As shown in Fig. 2 , species that cannot bind to S protein are marked in red, and species that can bind to S protein are marked in green. No correlation between genetic distance and the interaction of ACE2/S was found. Some Pets including dog (Canis lupus familiaris) and cat (Felis catus) potentially recognize S protein, indicating the importance to monitor the pets for SARS-CoV-2 infection. We found that four members of Circetidae including Mesocricetus auratus, Phodopus campbelli, Ictidomys tridecemlineatus, and Cricetulus griseus remained the key residues for association with S protein from SARS-CoV and SARS-CoV-2, though two members of Muridae (Rattus norvegicus, Mus musculus) could not bind to S protein. This founding suggested that Circetidae mammals could be developed as SARSr-CoV small animal models.
Fig. 2

Phylogenetic tree of mammalian ACE2 proteins. ACE2 sequences from a total of 42 mammals were analyzed by MEGA-X and the phylogenetic tree was constructed with JTT evolutionary model using Maximum Likelihood method. The red represents the species whose ACE2 cannot bind to S protein, and the green is the species whose ACE2 associate with S protein. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

Phylogenetic tree of mammalian ACE2 proteins. ACE2 sequences from a total of 42 mammals were analyzed by MEGA-X and the phylogenetic tree was constructed with JTT evolutionary model using Maximum Likelihood method. The red represents the species whose ACE2 cannot bind to S protein, and the green is the species whose ACE2 associate with S protein. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

Structure simulation of the protein complex of SARSr-CoV RBD and cat/dog/pangolin/Chinese hamster ACE2

We noticed that ACE2 from dog, cat, pangolin and Chinese hamster potentially associated with S protein (Table 1). Next, we predicted the structure of cat/dog/pangolin/Chinese hamster ACE2 with SARSr-CoV RBD. The structure of protein complex between RBD region of S protein of SARS-CoV and human ACE2 has been resolved (PDB: 2AJF) [7]. Recently, the structure of SARS-CoV-2 RBD with human ACE2 was also determined [16,17]. We used Chimera software to display homologous model, and obtained the interaction complex structure of RBD region of SARSr-CoV (SARS-CoV-2 and SARS-CoV) and cat/dog/pangolin/Chinese hamster ACE2. Overall, the RBM structures of S protein of SARS-CoV-2 and SARS-CoV are similar (Fig. 3 ). Interaction interface of SARSr-CoV RBD and cat/dog/pangolin/Chinese hamster ACE2 confirmed the potential interaction between SARS-CoV-2 and cat/dog/pangolin/Chinese hamster ACE2, indicating that these ACE2 could support SARS-CoV-2 entry. The AA in 82 position of human ACE2 is M82, while the corresponding AA in cat, dog, pangolin and Chinese hamster ACE2 is T82, T81, N82 and N82, respectively. The distance between F486 of SARS-CoV-2 S protein and the corresponding AA in ACE2 is 3.753Å for human (Fig. 1A), 2.695Å for dog (Fig. 3A), 3.753Å for cat (Fig. 3B), 1.621Å for pangolin (Fig. 3C), and 2.024Å for Chinese hamster (Fig. 3D), respectively. We concluded that N82 in ACE2 showed closer contact with F486 of SARS-CoV-2 S protein than M82 of ACE2.
Fig. 3

Structure simulation of SARSr-CoV RBD with ACE2 from dog, cat, pangolin and Chinese hamster. (A) Structural simulation of the protein complex of dog ACE2 and SARSr-CoV RBD. Dog ACE2, SARS-CoV-2 RBD, SARS-CoV RBD are in gold, blue, and green, respectively. (B) Structural simulation of the protein complex of cat ACE2 and SARSr-CoV RBD. Cat ACE2, SARS-CoV-2 RBD, and SARS-CoV RBD are in pulm, blue and green, respectively. (C) Structural simulation of the protein complex of pangolin ACE2 and SARSr-CoV RBD. Pangolin ACE2, SARS-CoV-2 RBD, and SARS-CoV RBD are in sandy brown, blue and green, respectively. (D) Structural simulation of the protein complex of Chinese hamster ACE2 and SARSr-CoV RBD. Chinese hamster ACE2, SARS-CoV-2 RBD, and SARS-CoV RBD are in dim gray, blue and green, respectively. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

Structure simulation of SARSr-CoV RBD with ACE2 from dog, cat, pangolin and Chinese hamster. (A) Structural simulation of the protein complex of dog ACE2 and SARSr-CoV RBD. Dog ACE2, SARS-CoV-2 RBD, SARS-CoV RBD are in gold, blue, and green, respectively. (B) Structural simulation of the protein complex of cat ACE2 and SARSr-CoV RBD. Cat ACE2, SARS-CoV-2 RBD, and SARS-CoV RBD are in pulm, blue and green, respectively. (C) Structural simulation of the protein complex of pangolin ACE2 and SARSr-CoV RBD. Pangolin ACE2, SARS-CoV-2 RBD, and SARS-CoV RBD are in sandy brown, blue and green, respectively. (D) Structural simulation of the protein complex of Chinese hamster ACE2 and SARSr-CoV RBD. Chinese hamster ACE2, SARS-CoV-2 RBD, and SARS-CoV RBD are in dim gray, blue and green, respectively. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

Discussion

The host tropism of zoonotic coronavirus is hybrid, and it is important to determine the natural host and host range of coronavirus. In the past two decades, SARS-CoV, MERS-CoV and SARS-CoV-2 have caused serious outbreaks of human infectious diseases. All the three human coronaviruses originated from bats, but the intermediate hosts were different. SARS-CoV is believed to come from the Paguma larvata [18], and the intermediate host of MERS-CoV is Camelus dromedaries [19]. The new coronavirus SARS-CoV-2 has recently caused a serious epidemic in China, but its intermediate hosts are not clear. S protein of SARS-CoV-2 interacts with human ACE2, which promotes the entry of SARS-CoV-2, indicating that human ACE2 is the receptor of SARS-CoV-2 [3]. ACE2 contains at least five key amino acids critical for binding S protein of SARSr-CoV [15]. Based on these five amino acids, we analyzed the corresponding amino acids of different mammals to determine which mammalian ACE2 could interact with S protein of human SARSr-CoV. By analyzing the protein sequence of mammalian ACE2, we found that the ACE2 of Camelus dromedarius, Procyon lotor, Rhinolophus ferrumequinum, Rattus norvegicus, Mus musculus, Ornithorhynchus anatinus, Loxodonta africana, Erinaceus europaeus, Nyctereutes procyonoides, Suricata suricatta, Dipodomys ordii, and Cavia porcellus lose the capability to associate with S protein (Table 1). These mammals could be ruled out from the potential host list for SARS-CoV-2. We found that S protein may bind to ACE2 from some wild mammals, which suggests that we should investigate whether these animals may be intermediate hosts for SARS-CoV-2. It has been reported that the RBM region in S protein of pangolin coronavirus is similar to that of S protein of SARS-CoV-2 [11,12], which may be involved in the recombination of SARS-CoV-2. We identified that N82 of pangolin ACE2 showed closer contact with RBD than human ACE2 (Fig. 3C), indicating that pangolin ACE2 might show better affinity to SARS-CoV-2. This finding further supports the hypothesis that pangolin is involved in SARS-CoV-2 evolution. In current study, only a limited list of wild mammals is covered. In the future, we should select more mammals for study. Although no SARS-CoV-2 has been found in domestic cats and dogs, cat/dog ACE2 may bind to S protein of SARS-CoV-2. In the future, we should pay attention to monitoring whether domestic cats and dogs could be infected by SARS-CoV-2. Animal model is an important tool in the study of infectious diseases. ACE2 of mice cannot interact with SARS-CoV-2, so it cannot be used as animal model of SARS-CoV-2 directly. Some studies have generated mice transfected with human ACE2 as the models to study SARS-CoV [20], and these mice can also be used as animal models for SARS-CoV-2 infection. Interestingly, we identified that N82 in ACE2 is closer to RBD than M82 (Fig. 3C and D), indicating a novel strategy to design an optimized ACE2 for SARS-CoV-2 infection. We speculated that small peptide based on N82 of ACE2 might show higher affinity to SARS-CoV-2 RBD. We proposed that if M82 in human ACE2 was mutated to N82, the modified human ACE2 will enhance SARS-CoV-2 infection. In the future, those ideas will be tested in cell culture and animal model. We noticed that the ACE2 proteins from Circetidae (Mesocricetus auratus, Phodopus campbelli, Ictidomys tridecemlineatus, and Cricetulus griseus) are capable to recognize RBD. Mesocricetus auratus (golden hamster) and Cricetulus griseus (Chinese hamster) are experimental animals and our finding indicates the possibility to develop small animal models for SARS-CoV-2 infection using Chinese hamster and golden hamster.

Declaration of competing interest

The authors declare that there are no conflicts of interest.
  17 in total

1.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

2.  MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms.

Authors:  Sudhir Kumar; Glen Stecher; Michael Li; Christina Knyaz; Koichiro Tamura
Journal:  Mol Biol Evol       Date:  2018-06-01       Impact factor: 16.240

3.  Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms.

Authors:  Biao Kan; Ming Wang; Huaiqi Jing; Huifang Xu; Xiugao Jiang; Meiying Yan; Weili Liang; Han Zheng; Kanglin Wan; Qiyong Liu; Buyun Cui; Yanmei Xu; Enmin Zhang; Hongxia Wang; Jingrong Ye; Guichang Li; Machao Li; Zhigang Cui; Xiaobao Qi; Kai Chen; Lin Du; Kai Gao; Yu-Teng Zhao; Xiao-Zhong Zou; Yue-Ju Feng; Yu-Fan Gao; Rong Hai; Dongzhen Yu; Yi Guan; Jianguo Xu
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

4.  Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection.

Authors:  Xiu-Hong Yang; Wei Deng; Zan Tong; Yan-Xia Liu; Lian-Feng Zhang; Hua Zhu; Hong Gao; Lan Huang; Ya-Li Liu; Chun-Mei Ma; Yan-Feng Xu; Ming-Xiao Ding; Hong-Kui Deng; Chuan Qin
Journal:  Comp Med       Date:  2007-10       Impact factor: 0.982

5.  Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins.

Authors:  Tommy Tsan-Yuk Lam; Na Jia; Ya-Wei Zhang; Marcus Ho-Hin Shum; Jia-Fu Jiang; Yi-Gang Tong; Hua-Chen Zhu; Yong-Xia Shi; Xue-Bing Ni; Yun-Shi Liao; Wen-Juan Li; Bao-Gui Jiang; Wei Wei; Ting-Ting Yuan; Kui Zheng; Xiao-Ming Cui; Jie Li; Guang-Qian Pei; Xin Qiang; William Yiu-Man Cheung; Lian-Feng Li; Fang-Fang Sun; Si Qin; Ji-Cheng Huang; Gabriel M Leung; Edward C Holmes; Yan-Ling Hu; Yi Guan; Wu-Chun Cao
Journal:  Nature       Date:  2020-03-26       Impact factor: 49.962

6.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

7.  Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.

Authors:  Yushun Wan; Jian Shang; Rachel Graham; Ralph S Baric; Fang Li
Journal:  J Virol       Date:  2020-03-17       Impact factor: 5.103

8.  A new coronavirus associated with human respiratory disease in China.

Authors:  Fan Wu; Su Zhao; Bin Yu; Yan-Mei Chen; Wen Wang; Zhi-Gang Song; Yi Hu; Zhao-Wu Tao; Jun-Hua Tian; Yuan-Yuan Pei; Ming-Li Yuan; Yu-Ling Zhang; Fa-Hui Dai; Yi Liu; Qi-Min Wang; Jiao-Jiao Zheng; Lin Xu; Edward C Holmes; Yong-Zhen Zhang
Journal:  Nature       Date:  2020-02-03       Impact factor: 49.962

9.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

10.  Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.

Authors:  Michael Letko; Andrea Marzi; Vincent Munster
Journal:  Nat Microbiol       Date:  2020-02-24       Impact factor: 17.745

View more
  146 in total

1.  Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2.

Authors:  Mohamad Hesam Shahrajabian; Wenli Sun; Qi Cheng
Journal:  Hum Vaccin Immunother       Date:  2020-08-12       Impact factor: 3.452

2.  Introduction on Coronavirus Disease (COVID-19) Pandemic: The Global Challenge.

Authors:  Nima Rezaei; Saboura Ashkevarian; Mahsa Keshavarz Fathi; Sara Hanaei; Zahra Kolahchi; Seyedeh-Sanam Ladi Seyedian; Elham Rayzan; Mojdeh Sarzaeim; Aida Vahed; Kawthar Mohamed; Sarah Momtazmanesh; Negar Moradian; Zahra Rahimi Pirkoohi; Noosha Sameeifar; Mahsa Yousefpour; Sepideh Sargoli; Saina Adiban; Aida Vahed; Niloufar Yazdanpanah; Heliya Ziaei; Amene Saghazadeh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  SARS-CoV-2, ACE2 expression, and systemic organ invasion.

Authors:  Usman M Ashraf; Ahmed A Abokor; Jonnelle M Edwards; Emily W Waigi; Rachel S Royfman; Syed Abdul-Moiz Hasan; Kathryn B Smedlund; Ana Maria Gregio Hardy; Ritu Chakravarti; Lauren Gerard Koch
Journal:  Physiol Genomics       Date:  2020-12-04       Impact factor: 3.107

4.  Genomic Variations in SARS-CoV-2 Genomes From Gujarat: Underlying Role of Variants in Disease Epidemiology.

Authors:  Madhvi Joshi; Apurvasinh Puvar; Dinesh Kumar; Afzal Ansari; Maharshi Pandya; Janvi Raval; Zarna Patel; Pinal Trivedi; Monika Gandhi; Labdhi Pandya; Komal Patel; Nitin Savaliya; Snehal Bagatharia; Sachin Kumar; Chaitanya Joshi
Journal:  Front Genet       Date:  2021-03-19       Impact factor: 4.599

Review 5.  Do Certain Biomarkers Predict Adverse Outcomes in Coronavirus Disease 2019?

Authors:  Hiba Narvel; Anam Sayed; Nida Narvel; Shreyas Yakkali; Tasleem Katchi
Journal:  J Clin Med Res       Date:  2021-04-27

Review 6.  SARS-CoV-2 viability under different meteorological conditions, surfaces, fluids and transmission between animals.

Authors:  María Fernández-Raga; Laura Díaz-Marugán; Marta García Escolano; Carlos Bort; Víctor Fanjul
Journal:  Environ Res       Date:  2020-10-02       Impact factor: 6.498

Review 7.  Genetically modified mouse models to help fight COVID-19.

Authors:  Channabasavaiah B Gurumurthy; Rolen M Quadros; Guy P Richardson; Larisa Y Poluektova; Suzanne L Mansour; Masato Ohtsuka
Journal:  Nat Protoc       Date:  2020-10-26       Impact factor: 13.491

Review 8.  SARS-CoV-2-Morphology, Transmission and Diagnosis during Pandemic, Review with Element of Meta-Analysis.

Authors:  Katarzyna Grudlewska-Buda; Natalia Wiktorczyk-Kapischke; Ewa Wałecka-Zacharska; Joanna Kwiecińska-Piróg; Katarzyna Buszko; Kamil Leis; Klaudia Juszczuk; Eugenia Gospodarek-Komkowska; Krzysztof Skowron
Journal:  J Clin Med       Date:  2021-05-03       Impact factor: 4.241

Review 9.  Should We Be Concerned about the Association of Diabetes Mellitus and Periodontal Disease in the Risk of Infection by SARS-CoV-2? A Systematic Review and Hypothesis.

Authors:  Miguel Angel Casillas Santana; Juan Antonio Arreguín Cano; Alejandro Dib Kanán; Farid Alonso Dipp Velázquez; Paulina Del Carmen Sosa Munguía; Gabriel Alejandro Martínez Castañón; Brenda Eréndida Castillo Silva; Carolina Sámano Valencia; Marco Felipe Salas Orozco
Journal:  Medicina (Kaunas)       Date:  2021-05-13       Impact factor: 2.430

Review 10.  Gamma irradiation-mediated inactivation of enveloped viruses with conservation of genome integrity: Potential application for SARS-CoV-2 inactivated vaccine development.

Authors:  Fouad A Abolaban; Fathi M Djouider
Journal:  Open Life Sci       Date:  2021-06-02       Impact factor: 0.938

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.